Countervail Cognitive and Cerebral Decline in Mild Cognitive Impairment Patients Using Non-medica… (NCT04546451) | Clinical Trial Compass
CompletedNot Applicable
Countervail Cognitive and Cerebral Decline in Mild Cognitive Impairment Patients Using Non-medical Interventions
Switzerland48 participantsStarted 2021-01-01
Plain-language summary
Cognitive decline represents a major threat among the deleterious effects of population aging. The investigators propose to conduct an RCT (randomized controlled trial) on the subpopulation of MCI patients, and examine whether intensive musical or psychomotor group interventions can improve their cognitive and sensorimotor functioning, as well as induce brain plasticity, compared to a passive healthy control group, matched for age, gender and education level. The 2 training regimens will take place twice a week over 6 months and will be provided by professionals in each field.
Who can participate
Age range60 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. MCI diagnosis by experts at the memory clinics
✓. MMSE score (Mini-Mental State Examination) \> 22 or MoCA (Montreal Cognitive Assessment) \> 18
✓. Hospital Anxiety and Depression Scale (HADS) \< 14 (\< 7/21 for anxiety and \< 7/21 for depression)
✓. Age between 60 and 80 years
✓. Right-handedness
✓. Fluent in French
✓. Able to give informed consent as documented by signature
Exclusion criteria
✕. Serious motor deficits
✕. Impaired/not-corrected hearing
✕. Serious physical and mental comorbidities
✕. Participation in physical or cognitive training over the last 12 months